Loading...

Roivant Sciences Ltd.

ROIVW•NASDAQ
Healthcare
Biotechnology
$2.75
$0.12(4.56%)

Roivant Sciences Ltd. (ROIVW) Stock Overview

Explore Roivant Sciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.8/100

Key Financials

Market Cap7.8B
P/E Ratio-47.81
EPS (TTM)$-4.09
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$7.17

ROIVW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Roivant Sciences Ltd. (ROIVW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $7.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -47.81 and a market capitalization of 7.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;